✦ LIBER ✦

Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of α-galactosidase A

✍ Scribed by Yoshiro Nagao; Haruko Nakashima; Yukiko Fukuhara; Michie Shimmoto; Akihiro Oshima; Yuji Ikari; Yoshio Mori; Hitoshi Sakuraba; Yoshiyuki Suzuki

Book ID: 115090174
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 310 KB
Volume: 39
Category: Article
ISSN: 0009-9163
DOI: 10.1111/j.1399-0004.1991.tb03018.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Residual activity of α-galactosidase A i

Residual activity of α-galactosidase A in Fabry's disease

✍ Giovanni Romeo; Michele D'Urso; Alfredo Pisacane; Eric Blum; Antonio Falco; Anna 📂 Article 📅 1975 🏛 Springer 🌐 English ⚖ 602 KB

The alpha-galactosidase A activity from fibroblasts of five Fabry patients and five controls has been separated from alpha-galactosidase B through small DEAE-cellulose columns and in some experiments by treatment of the fibroblast extracts with Sepharose coupled to anti-alpha-galactosidase B antibod

Prevalence of Fabry Disease (FD) in fema

Prevalence of Fabry Disease (FD) in female patients with late-onset hypertrophic cardiomyopathy (HCM)

✍ C. Chimenti; M. Pieroni; E. Morgante 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Novel sequence variants of the α-galacto

Novel sequence variants of the α-galactosidase A gene in patients with Fabry disease

✍ Melinda Erdős; Krisztina Németh; Beáta Tóth; Tamás Constantin; Éva Rákóczi; Andr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Identification of novel mutations in the

Identification of novel mutations in the α-galactosidase A gene in patients with Fabry disease: Pitfalls of mutation analyses in patients with low α-galactosidase A activity

✍ Makoto Yoshimitsu; Koji Higuchi; Masaaki Miyata; Sean Devine; Andre Mattman; San 📂 Article 📅 2011 🏛 Elsevier 🌐 Japanese ⚖ 595 KB

Targeted sequencing of over 4000 hypertr

Targeted sequencing of over 4000 hypertrophic cardiomyopathy (HCM) patients for mutations causing HCM and Fabry disease: HCM mutations frequent in patients with GLA later-onset mutations, polymorphisms, and variants

✍ Desnick, Robert J.; Doheny, Dana O. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Role of Ser-65 in the Activity of α-Gala

Role of Ser-65 in the Activity of α-Galactosidase A: Characterization of a Point Mutation (S65T) Detected in a Patient with Fabry Disease

✍ Satoshi Ishii; Yoshiyuki Suzuki; Jian-Qiang Fan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 201 KB